Physician profile
Mark Henry Gooch
NPI 1861494098
$1,944.93
in general payments reported to CMS, 2019-2025
20 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $167 · 2021: $256 · 2022: $237 · 2023: $220 · 2024: $274 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $239.87 | 2019-2025 | Cequa |
| Allergan, INC. | $229.54 | 2019-2021 | |
| Harrow Eye, LLC | $178.34 | 2024-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $168.53 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $154.42 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $143.42 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $123.56 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Tarsus Pharmaceuticals, INC. | $117.03 | 2024-2025 | Xdemvy |
| Abbvie INC. | $102.95 | 2023-2025 | |
| Horizon Therapeutics Plc | $90.80 | 2019-2023 | Tepezza |
| Kala Pharmaceuticals, INC. | $72.50 | 2021-2022 | |
| Alcon Vision LLC | $66.00 | 2022-2025 | Simbrinza, Eysuvis |
| Thea Pharma INC. | $65.70 | 2024 | Iyuzeh |
| Shire North American Group INC | $53.23 | 2019 | |
| Rayner Intraocular Lenses Limited | $33.07 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.75 | 2025 | Tepezza |
| Coopervision INC. | $26.66 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $16.52 | 2022 | |
| Rxsight INC | $16.50 | 2024 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $15.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gooch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.